MoneyWorks4Me

The company witnessed a 15.07% growth in the revenue at Rs. 1772.82 millions for the quarter ended June 2026 as compared to Rs. 1540.67 millions during the year-ago period.An average growth of 30.93% was recorded for the quarter ended June 2026 to Rs. 362.34  millions from Rs. 276.75 millions.Operating profit surged to 516.96 millions from the corresponding previous quarter of 390.76 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 1772.82 1540.67 15.07 1772.82 1540.67 15.07 6710.30 6232.30 7.67
Other Income 242.65 152.72 58.89 242.65 152.72 58.89 334.54 224.77 48.84
PBIDT 516.96 390.76 32.30 516.96 390.76 32.30 1311.37 1239.71 5.78
Interest 2.59 2.10 23.33 2.59 2.10 23.33 10.13 18.83 -46.20
PBDT 514.37 388.66 32.34 514.37 388.66 32.34 1301.24 1220.88 6.58
Depreciation 38.84 34.77 11.71 38.84 34.77 11.71 145.00 128.99 12.41
PBT 475.53 353.89 34.37 475.53 353.89 34.37 1156.24 1091.89 5.89
TAX 113.19 77.14 46.73 113.19 77.14 46.73 277.31 268.42 3.31
Deferred Tax 59.66 35.91 66.14 59.66 35.91 66.14 -0.31 15.15 -102.05
PAT 362.34 276.75 30.93 362.34 276.75 30.93 878.93 823.47 6.73
Equity 200.30 200.30 0.00 200.30 200.30 0.00 200.30 200.30 0.00
PBIDTM(%) 29.16 25.36 14.97 29.16 25.36 14.97 19.54 19.89 -1.76

Lincoln Pharma Share Price

617.30 -5.05 (-0.81%)
21-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1900.90
Dr. Reddys Labs. 1175.00
Cipla 1426.20
Lupin 2193.00
Zydus Lifesciences 1120.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: